Corporate Profile

Impel Pharmaceuticals, Inc. is a commercial-stage pharmaceutical company focused on utilizing its proprietary technology to develop and commercialize transformative therapies for patients suffering from diseases with high unmet needs across various disease areas in addition to the central nervous system. The Company is rapidly advancing a product pipeline that pairs its proprietary Precision Olfactory Delivery (POD®) technology with well- established therapeutics, including Trudhesa® for the acute treatment of migraine, INP105 for the acute treatment of agitation and aggression in patients with autism, and INP107 for OFF episodes in Parkinson’s disease. To learn more about Impel Pharmaceuticals, please visit our website at

Stock Information

Data Provided by Refinitiv. Minimum 15 minutes delayed.

News Releases

Latest Earnings

Show all